Exogenous FGF9 administration was found to increase depression-like behaviors, and exogenous FGF9 knockdown in the dentate gyrus improved anxiety-like behavior in rats (Aurbach et al., 2015). This evidence concerns the gene FGF9 and major depressive disorder.